pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
PERAMPANEL
PERAMPANEL (PERAMPANEL)
Generalized Seizures
$CPRXCATALYST PHARMACEUTICALS, INC.
1 catalysts
Marketed
sibeprenlimab
Voyxact (sibeprenlimab-szsi)
Sicca Syndrome (Sjogren)
Visterra Inc
1 catalysts
Marketed
nafarelin acetate
Synarel (nafarelin acetate)
Central Precocious Puberty
$PFEPFIZER INC
28 catalysts
← prev
page 28 of 231
next →
131
Pain89
Neurology1
Marketed
teprotumumab
Tepezza (teprotumumab)
Graves' Ophthalmopathy
Horizon Therapeutics USA Inc
8 catalysts
Marketed
(atezolizumab + hyaluronidase (human recombinant))
Tecentriq Hybreza ((atezolizumab + hyaluronidase-tqjs (human recombinant)))
Hepatocellular Carcinoma
Genentech Inc
5 catalysts
Marketed
(hyaluronidase (recombinant, human) + nivolumab)
Opdivo Qvantig ((hyaluronidase-nvhy (recombinant, human) + nivolumab))
Adenocarcinoma Of The Gastroesophageal Junction
Bristol-Myers Squibb Co
5 catalysts
Marketed
amlodipine besylate
Amlodipine Besylate (amlodipine besylate)
Chronic Stable Angina
China Resources Saike Pharmaceutical Co Ltd
5 catalysts
Marketed
Calan
Verapamil Hydrochloride (verapamil hydrochloride)
Atrial Fibrillation
Exela Pharma Sciences LLC
2 catalysts
Marketed
CLADRIBINE
CLADRIBINE (CLADRIBINE)
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono Inc
1 catalysts
Marketed
TAZAROTENE
TAZAROTENE (TAZAROTENE)
Idiopathic Pulmonary Fibrosis
Retinoic acid receptor
$GRIGRI Bio, Inc.
1 catalysts
Marketed
enfortumab vedotin
Padcev (enfortumab vedotin-ejfv)
Muscle Invasive Bladder Cancer (MIBC)
Nectin-4Tubulin
Astellas Pharma Inc
12 catalysts
Marketed
ALBUTEROL SULFATE
ALBUTEROL SULFATE (ALBUTEROL SULFATE)
Bronchospasm
Sentiss Pharmaceuticals LLC
4 catalysts
Marketed
FULVESTRANT
FULVESTRANT (FULVESTRANT)
Hormone Sensitive Breast Cancer
Eagle Pharmaceuticals Inc
4 catalysts
Marketed
URSODIOL
URSODIOL (URSODIOL)
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
RK Pharma Inc
3 catalysts
Marketed
BACLOFEN
BACLOFEN (BACLOFEN)
Muscle Spasticity
Beximco Pharmaceuticals USA Inc
2 catalysts
Marketed
cosibelimab
Unloxcyt (cosibelimab-ipdl)
Cutaneous Squamous Cell Carcinoma (cSCC)
Checkpoint Therapeutics Inc
2 catalysts
Marketed
selpercatinib
Retevmo (selpercatinib)
Anaplastic Thyroid Cancer
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RETProto-oncogene tyrosine-protein kinase receptor Ret
Eli Lilly and Co
19 catalysts
Marketed
Clobetasol Propionate Teva
Clobetasol Propionate (clobetasol propionate)
Atopic Dermatitis (Atopic Eczema)
Teva Pharmaceuticals USA Inc
1 catalysts
Marketed
HEPARIN SODIUM
HEPARIN SODIUM (HEPARIN SODIUM)
Antithrombin-III
$PFEPFIZER INC
53 catalysts
Marketed
ropinirole hydrochloride ER
Ropinirole Hydrochloride (ropinirole hydrochloride)
Parkinson's Disease
Elite Laboratories Inc
11 catalysts
Marketed
selumetinib sulfate
Koselugo (selumetinib sulfate)
Plexiform Neurofibroma
AstraZeneca Pharmaceuticals LP
7 catalysts
Marketed
NILOTINIB HYDROCHLORIDE
NILOTINIB HYDROCHLORIDE (NILOTINIB HYDROCHLORIDE)
Hetero Labs Ltd
2 catalysts
Marketed
tarlatamab
Imdelltra (tarlatamab-dlle)
Small-Cell Lung Cancer
$AMGNAMGEN INC
2 catalysts
Marketed
sevabertinib
Hyrnuo (sevabertinib)
Non-Small Cell Lung Cancer
Bayer AG
1 catalysts
Marketed
PYZCHIVA
PYZCHIVA (USTEKINUMAB-TTWE)
Samsung Bioepis Co Ltd
13 catalysts
Marketed
TAMSULOSIN HYDROCHLORIDE
TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE)
Storage Symptoms of Benign Prostatic Hyperplasia
Synthon Pharmaceuticals Inc (Inactive)
2 catalysts
Marketed
DICHLORPHENAMIDE
DICHLORPHENAMIDE (DICHLORPHENAMIDE)
Hyperkalemic Periodic Paralysis (Primary Hyperkalemic Periodic Paralysis)
Torrent Pharma Inc
1 catalysts
Marketed
FLUPHENAZINE HYDROCHLORIDE
FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)
Hetero Labs Ltd
1 catalysts
Marketed
plozasiran sodium
Redemplo (plozasiran sodium)
Hypertriglyceridemia
$ARWRARROWHEAD PHARMACEUTICALS, INC.
1 catalysts
Marketed
alitretinoin
Panretin (alitretinoin)
Kaposi Sarcoma
Galephar Pharmaceutical Research Inc
5 catalysts